Tuesday, November 13, 2018
Call for Abstracts: Georgia CTSA 2019 Conference
Abstract submission deadline: Monday, 12/3 This conference takes place Thursday 2/28/2019- Friday, 3/1/2019 at Callaway Resort and Gardens in Pine Mountain GA. The goal of the Georgia Clinical & Translational Science Conference is to bring together researchers from across the state to present the best new clinical and translational research and build collaborative relationships. Abstract submission form | Read more
Need help navigating the Department of Medicine Research Administration Service (RAS) Unit? The DOM RAS Unit has issued a one-page document to assist you in working your way through the grant submission process starting with pre-award.
Read more (PDF) Reminder: Georgia CTSA KL2 Program Clinical & Translational research career development program for junior faculty members
Deadline: Friday, 3/1/2019 The goal of the program is to support and enhance career development for junior faculty (MD, PhD, MD/PhD, or PharmD) committed to a career in clinical and/or translational research. The Georgia CTSA program is committed to assisting junior faculty at partner institutions to become independent, established, and ethical clinical and/or translational research investigators. Register for the free two-session KL2 Application Workshops on December 4 and 11. Read more Reminder: Georgia CTSA TL1
(T32-like) training grant clinical & translational research training
Deadline: Friday, 3/15/2019 Now accepting applications for the Georgia CTSA TL1 (T32- like) training grant. Clinical and translational research training including the Master of Science in Clinical Research (MSCR) Program for Postdoctoral Trainees (resident and fellow physicians, PhD postdocs, PharmD residents). Free TL1 application workshop: Friday, 11/29 at 9:30 a.m. Read more
Data Analytics and Statistics Core The Data Analytics and Biostatistics (DAB) Core seeks to provide high-quality biostatistics and IT Data management services to the Department of Medicine by leveraging existing services in the Rollins School of Public Health and the Information Technology Department. Read more
Funding & Award Opportunities
Weekly NIH funding opportunities and notices
Federal funding opportunities for public health faculty
Searchable database of internal medicine funding opportunities Novel approaches for relating genetic variation to function and disease (R34/R44 clinical trial not allowed)
Deadline: Tuesday, 12/4 (LOI) This program announcement aims to support the development of novel and generalizable commercial approaches to study how genetic variants lead to differences in function and to study how such functional differences affect human health and disease processes or how this knowledge can be used clinically. Read more No (type) one left behind: Expanding artificial pancreas adoption and access among targeted populations
Deadline: Wednesday, 12/5 JDRF is committed to expanding the reach of artificial pancreas (AP) systems and the benefits they can provide to people with type 1 diabetes (T1D) – of all ages and stages. Read more Accelerating Colorectal Cancer Screening and follow-up through Implementation Science (ACCSIS, Second wave) (UG3/UH3 clinical trial required)
Deadline: Tuesday, 12/11 (LOI) The purpose of this FOA is to promote research in colorectal cancer (CRC) screening, follow-up, and referral-to-care in regions of the United States (U.S.) where screening rates are below national standards. Read more Polycystic Kidney Disease (PKD) Foundation Research Grant
Deadline: Monday, 1/7/2019 The PKD Foundations principal mission is to support basic, translational and clinical research that will benefit patients with ARPKD and ADPKD. The Foundation accomplishes this in part through funding of basic and translational research. Read more Alliance for Academic Internal Medicine (AAIM) Innovation Grants
Deadline: Friday, 1/18/2019 Do you have an inventive or novel approach that addresses an existing or emerging problem that impacts multiple AAIM associations? If so, please submit a Letter of Intent (LoI) that would summarize your original concept. The Innovation Grants Program awards $2,500 to a single institution and $5,000 to multiple institutions for these innovative ideas. Read more Human Islet Research Network- Consortium on Targeting and Regeneration (HIRN-CTAR) (U01 clinical trial not allowed)
Deadline: Friday, 1/25/2019 This Funding Opportunity Announcement (FOA) solicits applications for the Consortium on Targeting and Regeneration (CTAR) that supports the development of innovative strategies to increase or protect functional human beta cell mass in patients with Type-1 Diabetes (T1D) through the controlled manipulation of beta cell replication, islet cell plasticity, and the reprogramming of pancreatic non-beta cells into beta-like cells, or through shielding the residual beta cell mass from the autoimmune environment. CTAR is part of the Human Islet Research Network (HIRN). Read more The
Entelligence Young Investigator Program
Deadline: Friday, 2/1/2019 The ENTELLIGENCE Young Investigator Program is a US-based research program consistent with Actelion Pharmaceutical US, Inc.’s commitment to basic science, translational, and clinical research in the area of pulmonary vascular disease. Read more Research project grant (Parent R01 clinical trial required)
Deadline: Standard Dates Apply This Parent Funding Opportunity Announcement requires that at least 1 clinical trial be proposed. The proposed project must be related to the programmatic interests of one or more of the participating NIH Institutes and Centers (ICs) based on their scientific missions. Read more
Mikael El Chami (Cardiology) received funding from AMC Medical Research B.V. for a project entitled, “A prospective randomized comparative trial of subcutaneous implantable cardioverter defibrillator implantation with and without defibrillator testing.” Evan Anderson (Infectious Diseases) received funding from Pfizer for a project entitled, “RSV in adults.” Srihari Veeraraghavan, Micah Fisher, Priyanka Rajaram (Pulmonary), Athan Tiliakos, Katina Tsagaris (Rheumatology) received funding from Boehringer Ingelheim for a project entitled, “An open-label extension trial to assess the long-term safety of nintedanib in patients with systemic sclerosis associated
interstitial lung disease.”
Have you or a colleague recently received an award or grant funding?
Division Research Seminars
Thursday, 11/15, at 8 a.m. in the Whitehead, Conference Room 200
Pulmonary Division Research Seminar: “The gut-lung axis: alcohol-induced intestinal dysbiosis impairs pulmonary host defense” (Derrick Samuelson, PhD, Louisiana State University Health Science Center)
Thursday, 11/15, at 8 a.m. in the Grace Crum Rollins Building, Rita Anne Rollins Room, 8th floor, SPH
Infectious Disease Seminar: “Jak inhibitors towards a functional cure or eradication of HIV-1 ” (Christina Gavegnano, PhD)
Friday, 11/16, at noon in the Hurst Conference Room, E450
Clinical Cardiovascular Research Conference: “Using healthcare claims to study comparative effectiveness of cardiovascular interventions: The case of oral anticoagulants in atrial fibrillation” (Alvaro Alonso, MD, PhD)
Recent Notable Publications
Russell Kempker (Infectious Diseases)
Graciaa DS, Machaidze M, Kipiani M, Buziashvili M, et al. “A survey of the tuberculosis physician workforce in the country of Georgia.” Int J Tuberc Lung Dis. 2018 Nov 1;22(11):1286-1292. Read more Emad Qayed (Digestive Diseases) Mayssan Muftah (General Medicine/Geriatrics)
Qayed E, Muftah M. “Frequency of hospital readmission and care fragmentation in gastroparesis: A nationwide analysis.” World J Gastrointest Endosc. 2018 Sep 16;10(9):200-209. Read more Rushikesh Shah, Emad Qayed (Digestive Diseases)
Shah R, Qayed E. “Outcomes and predictors of readmissions with GI bleeding in patients with left ventricular assist devices.” South Med J 2018. Nov;111(11):666-673. Read more
Kathy Griendling (Cardiology)
Li L, Lai EY, Luo Z, Solis G, et al. “High salt enhances reactive oxygen species and angiotensin II contractions of glomerular afferent arterioles from mice with reduced renal mass.” Hypertension. 2018 Nov;72(5):1208-1216. Read more
Reminder: CCTR Seminar- “Rationale, design, update, and lessons learned from the NHLBI-sponsored kids-DOTT multinational RCT”
Wednesday, 11/13 at 3 p.m. in the Health Services Research Building Auditorium. Neil Goldenberg, MD, PhD Professor of Pediatrics & Medicine, Johns Hopkins University, School of Medicine, Director of Research, Johns Hopkins All Children’s Hospital, Chief Research Officer, All Children’s Research Institute, Director, Thrombosis Program, JHAC Cancer & Blood Disorder Institute, Director, Stroke Program, JHAC Institute for Brain Protection Sciences presents this seminar as part of the Pediatric Research Alliance seminar series. Read more (PDF)
Reminder: Research Resources 101- "eIACUC protocol submission: Managing change and streamlining efforts"
Thursday, 11/15 at noon in SOM 170A. David Martin, PhD, CPIA presents this November seminar. Click here or use meeting ID,206-860-575, to participate via a mobile device. Register | Read more
Elena Dolmatova
Division of Cardiology
What is your professional background?
I obtained my MD in 2008 from Moscow State University. During my time in medical school, I truly enjoyed unraveling the intricacies of disease pathogenesis and how medication, lifestyle modifications, and other interventions could mediate these processes. My love for research and my long-standing fascination with cardiac physiology spurred me to pursue a post-doctoral fellowship in cardiovascular research at Harvard Medical School, where my studies focused on the molecular mechanisms triggering the development of ventricular arrhythmias as well as the functional genomics of atrial fibrillation. After fruitful years in basic science, I continued my clinical training in Internal Medicine at Rutgers University, where my scientific efforts focused mainly on population-based outcome studies. Upon completion of my residency training, I joined Emory University as a cardiology fellow.
In what division do you work, and who is your mentor?
I am excited to join the Dr. Kathy Griendling’s laboratory in the Division of Cardiology for the research years of my fellowship and to broaden my perspective of cardiovascular biology.
Briefly describe your research. Why is it important?
Sepsis constitutes a major cause of morbidity and mortality worldwide by causing life-threatening organ dysfunction, with the heart as one of the most frequently affected organs. My current project focuses on the role of Poldip2 in sepsis-induced cardiomyopathy aiming to discern the molecular mechanisms underlying its role and to identify novel therapeutic targets to treat this life-threatening condition.
What do you like most about Emory?
From the first day, Emory really impressed me by its warm and collaborative atmosphere.
What is your favorite movie or TV show?
As for most of us, I believe, it varies at different times, but the two latest ones that I enjoyed were the documentary series World War II: Countdown to Victory and The Unknown War.
What do you like to do in your spare time?
I enjoy hiking, mountain skiing, singing songs with the guitar (mostly in Russian), writing poems (mostly in English) and, of course, spending time with my family, watching our daughter grow up. It is indeed a very special experience to participate in those activities that one gets to revisit and enjoy (once again, but in a different capacity) when one has kids.
"What's Up" is brought to you by the Emory University Department of Medicine's Research Community.
View the DOM Research website here
|